HUA MEDICINE(02552) - 2025 H1 - Earnings Call Transcript

Hua Medicine (02552) H1 2025 Earnings Call August 28, 2025 08:00 PM ET Company ParticipantsLi Chen - Founder, Executive Director & CEOGeorge Lin - EVP & Chief Strategy OfficerLi ChenTo our medicine 2025 interim result presentation. George and I will share our status and then major progress at biomedicine in the '25 and then give you our view for a really strong growth in the next year and then coming years. For dorzagliatin, we are intended to treat diabetes. And as you may know, there has been nine classes ...